Global Blood Tests for Alzheimer's Diagnosis Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our latest research, the global Blood Tests for Alzheimer's Diagnosis market size will reach USD million in 2031, growing at a CAGR of %over the analysis period.
Blood tests for Alzheimer's diagnosis are emerging as a promising tool for early detection and monitoring of the disease. These tests aim to identify biomarkers associated with Alzheimer's, such as amyloid-beta and tau proteins, which are indicators of the characteristic plaques and tangles in the brain. Advances in technology have made it possible to measure these proteins with high sensitivity and specificity in the blood. This non-invasive approach offers a more accessible, cost-effective, and less burdensome alternative to traditional methods like cerebrospinal fluid analysis and neuroimaging. Blood tests can aid in early diagnosis, potentially leading to earlier intervention and better management of Alzheimer's disease.
This report is a detailed and comprehensive analysis for global Blood Tests for Alzheimer's Diagnosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts, in consumption value ($ Million), 2020-2031
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Blood Tests for Alzheimer's Diagnosis market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood Tests for Alzheimer's Diagnosis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood Tests for Alzheimer's Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Quanterix, Quest Diagnostics, C?N Diagnostics, Fujirebio, Diadem, Labcorp, Neurocode, Cognitact, Vazyme International, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Blood Tests for Alzheimer's Diagnosis market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Blood Tests for Alzheimer's Diagnosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Blood Tests for Alzheimer's Diagnosis, with revenue, gross margin, and global market share of Blood Tests for Alzheimer's Diagnosis from 2020 to 2025.
Chapter 3, the Blood Tests for Alzheimer's Diagnosis competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Blood Tests for Alzheimer's Diagnosis market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Tests for Alzheimer's Diagnosis.
Chapter 13, to describe Blood Tests for Alzheimer's Diagnosis research findings and conclusion.
Blood tests for Alzheimer's diagnosis are emerging as a promising tool for early detection and monitoring of the disease. These tests aim to identify biomarkers associated with Alzheimer's, such as amyloid-beta and tau proteins, which are indicators of the characteristic plaques and tangles in the brain. Advances in technology have made it possible to measure these proteins with high sensitivity and specificity in the blood. This non-invasive approach offers a more accessible, cost-effective, and less burdensome alternative to traditional methods like cerebrospinal fluid analysis and neuroimaging. Blood tests can aid in early diagnosis, potentially leading to earlier intervention and better management of Alzheimer's disease.
This report is a detailed and comprehensive analysis for global Blood Tests for Alzheimer's Diagnosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts, in consumption value ($ Million), 2020-2031
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Blood Tests for Alzheimer's Diagnosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Blood Tests for Alzheimer's Diagnosis market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood Tests for Alzheimer's Diagnosis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood Tests for Alzheimer's Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Quanterix, Quest Diagnostics, C?N Diagnostics, Fujirebio, Diadem, Labcorp, Neurocode, Cognitact, Vazyme International, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Blood Tests for Alzheimer's Diagnosis market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Single Molecule Immunoassay Array Analysis
- Chemiluminescence Method
- Fluorescence PCR Method
- Others
- Clinical Diagnosis
- Research
- Roche
- Quanterix
- Quest Diagnostics
- C?N Diagnostics
- Fujirebio
- Diadem
- Labcorp
- Neurocode
- Cognitact
- Vazyme International
- KingMed Diagnostics
- Hoyotek
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Blood Tests for Alzheimer's Diagnosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Blood Tests for Alzheimer's Diagnosis, with revenue, gross margin, and global market share of Blood Tests for Alzheimer's Diagnosis from 2020 to 2025.
Chapter 3, the Blood Tests for Alzheimer's Diagnosis competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Blood Tests for Alzheimer's Diagnosis market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Blood Tests for Alzheimer's Diagnosis.
Chapter 13, to describe Blood Tests for Alzheimer's Diagnosis research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Blood Tests for Alzheimer's Diagnosis by Type
1.3.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type in 2024
1.3.3 Single Molecule Immunoassay Array Analysis
1.3.4 Chemiluminescence Method
1.3.5 Fluorescence PCR Method
1.3.6 Others
1.4 Global Blood Tests for Alzheimer's Diagnosis Market by Application
1.4.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Clinical Diagnosis
1.4.3 Research
1.5 Global Blood Tests for Alzheimer's Diagnosis Market Size & Forecast
1.6 Global Blood Tests for Alzheimer's Diagnosis Market Size and Forecast by Region
1.6.1 Global Blood Tests for Alzheimer's Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Blood Tests for Alzheimer's Diagnosis Market Size by Region, (2020-2031)
1.6.3 North America Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2020-2031)
1.6.4 Europe Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2020-2031)
1.6.6 South America Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.1.4 Roche Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Roche Recent Developments and Future Plans
2.2 Quanterix
2.2.1 Quanterix Details
2.2.2 Quanterix Major Business
2.2.3 Quanterix Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.2.4 Quanterix Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Quanterix Recent Developments and Future Plans
2.3 Quest Diagnostics
2.3.1 Quest Diagnostics Details
2.3.2 Quest Diagnostics Major Business
2.3.3 Quest Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.3.4 Quest Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Quest Diagnostics Recent Developments and Future Plans
2.4 C?N Diagnostics
2.4.1 C?N Diagnostics Details
2.4.2 C?N Diagnostics Major Business
2.4.3 C?N Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.4.4 C?N Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 C?N Diagnostics Recent Developments and Future Plans
2.5 Fujirebio
2.5.1 Fujirebio Details
2.5.2 Fujirebio Major Business
2.5.3 Fujirebio Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.5.4 Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Fujirebio Recent Developments and Future Plans
2.6 Diadem
2.6.1 Diadem Details
2.6.2 Diadem Major Business
2.6.3 Diadem Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.6.4 Diadem Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Diadem Recent Developments and Future Plans
2.7 Labcorp
2.7.1 Labcorp Details
2.7.2 Labcorp Major Business
2.7.3 Labcorp Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.7.4 Labcorp Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Labcorp Recent Developments and Future Plans
2.8 Neurocode
2.8.1 Neurocode Details
2.8.2 Neurocode Major Business
2.8.3 Neurocode Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.8.4 Neurocode Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Neurocode Recent Developments and Future Plans
2.9 Cognitact
2.9.1 Cognitact Details
2.9.2 Cognitact Major Business
2.9.3 Cognitact Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.9.4 Cognitact Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Cognitact Recent Developments and Future Plans
2.10 Vazyme International
2.10.1 Vazyme International Details
2.10.2 Vazyme International Major Business
2.10.3 Vazyme International Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.10.4 Vazyme International Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Vazyme International Recent Developments and Future Plans
2.11 KingMed Diagnostics
2.11.1 KingMed Diagnostics Details
2.11.2 KingMed Diagnostics Major Business
2.11.3 KingMed Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.11.4 KingMed Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 KingMed Diagnostics Recent Developments and Future Plans
2.12 Hoyotek
2.12.1 Hoyotek Details
2.12.2 Hoyotek Major Business
2.12.3 Hoyotek Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.12.4 Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Hoyotek Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Blood Tests for Alzheimer's Diagnosis Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Blood Tests for Alzheimer's Diagnosis by Company Revenue
3.2.2 Top 3 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2024
3.2.3 Top 6 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2024
3.3 Blood Tests for Alzheimer's Diagnosis Market: Overall Company Footprint Analysis
3.3.1 Blood Tests for Alzheimer's Diagnosis Market: Region Footprint
3.3.2 Blood Tests for Alzheimer's Diagnosis Market: Company Product Type Footprint
3.3.3 Blood Tests for Alzheimer's Diagnosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Blood Tests for Alzheimer's Diagnosis Consumption Value and Market Share by Type (2020-2025)
4.2 Global Blood Tests for Alzheimer's Diagnosis Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2020-2025)
5.2 Global Blood Tests for Alzheimer's Diagnosis Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2031)
6.2 North America Blood Tests for Alzheimer's Diagnosis Market Size by Application (2020-2031)
6.3 North America Blood Tests for Alzheimer's Diagnosis Market Size by Country
6.3.1 North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2031)
6.3.2 United States Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
6.3.3 Canada Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
6.3.4 Mexico Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2031)
7.2 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2031)
7.3 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country
7.3.1 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2031)
7.3.2 Germany Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
7.3.3 France Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
7.3.5 Russia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
7.3.6 Italy Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size by Region
8.3.1 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2020-2031)
8.3.2 China Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
8.3.3 Japan Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
8.3.4 South Korea Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
8.3.5 India Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
8.3.7 Australia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2031)
9.2 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2031)
9.3 South America Blood Tests for Alzheimer's Diagnosis Market Size by Country
9.3.1 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2031)
9.3.2 Brazil Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
9.3.3 Argentina Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Country
10.3.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2031)
10.3.2 Turkey Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
10.3.4 UAE Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Blood Tests for Alzheimer's Diagnosis Market Drivers
11.2 Blood Tests for Alzheimer's Diagnosis Market Restraints
11.3 Blood Tests for Alzheimer's Diagnosis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Blood Tests for Alzheimer's Diagnosis Industry Chain
12.2 Blood Tests for Alzheimer's Diagnosis Upstream Analysis
12.3 Blood Tests for Alzheimer's Diagnosis Midstream Analysis
12.4 Blood Tests for Alzheimer's Diagnosis Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Blood Tests for Alzheimer's Diagnosis by Type
1.3.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type in 2024
1.3.3 Single Molecule Immunoassay Array Analysis
1.3.4 Chemiluminescence Method
1.3.5 Fluorescence PCR Method
1.3.6 Others
1.4 Global Blood Tests for Alzheimer's Diagnosis Market by Application
1.4.1 Overview: Global Blood Tests for Alzheimer's Diagnosis Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Clinical Diagnosis
1.4.3 Research
1.5 Global Blood Tests for Alzheimer's Diagnosis Market Size & Forecast
1.6 Global Blood Tests for Alzheimer's Diagnosis Market Size and Forecast by Region
1.6.1 Global Blood Tests for Alzheimer's Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Blood Tests for Alzheimer's Diagnosis Market Size by Region, (2020-2031)
1.6.3 North America Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2020-2031)
1.6.4 Europe Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2020-2031)
1.6.6 South America Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.1.4 Roche Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Roche Recent Developments and Future Plans
2.2 Quanterix
2.2.1 Quanterix Details
2.2.2 Quanterix Major Business
2.2.3 Quanterix Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.2.4 Quanterix Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Quanterix Recent Developments and Future Plans
2.3 Quest Diagnostics
2.3.1 Quest Diagnostics Details
2.3.2 Quest Diagnostics Major Business
2.3.3 Quest Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.3.4 Quest Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Quest Diagnostics Recent Developments and Future Plans
2.4 C?N Diagnostics
2.4.1 C?N Diagnostics Details
2.4.2 C?N Diagnostics Major Business
2.4.3 C?N Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.4.4 C?N Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 C?N Diagnostics Recent Developments and Future Plans
2.5 Fujirebio
2.5.1 Fujirebio Details
2.5.2 Fujirebio Major Business
2.5.3 Fujirebio Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.5.4 Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Fujirebio Recent Developments and Future Plans
2.6 Diadem
2.6.1 Diadem Details
2.6.2 Diadem Major Business
2.6.3 Diadem Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.6.4 Diadem Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Diadem Recent Developments and Future Plans
2.7 Labcorp
2.7.1 Labcorp Details
2.7.2 Labcorp Major Business
2.7.3 Labcorp Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.7.4 Labcorp Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Labcorp Recent Developments and Future Plans
2.8 Neurocode
2.8.1 Neurocode Details
2.8.2 Neurocode Major Business
2.8.3 Neurocode Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.8.4 Neurocode Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Neurocode Recent Developments and Future Plans
2.9 Cognitact
2.9.1 Cognitact Details
2.9.2 Cognitact Major Business
2.9.3 Cognitact Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.9.4 Cognitact Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Cognitact Recent Developments and Future Plans
2.10 Vazyme International
2.10.1 Vazyme International Details
2.10.2 Vazyme International Major Business
2.10.3 Vazyme International Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.10.4 Vazyme International Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Vazyme International Recent Developments and Future Plans
2.11 KingMed Diagnostics
2.11.1 KingMed Diagnostics Details
2.11.2 KingMed Diagnostics Major Business
2.11.3 KingMed Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.11.4 KingMed Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 KingMed Diagnostics Recent Developments and Future Plans
2.12 Hoyotek
2.12.1 Hoyotek Details
2.12.2 Hoyotek Major Business
2.12.3 Hoyotek Blood Tests for Alzheimer's Diagnosis Product and Solutions
2.12.4 Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Hoyotek Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Blood Tests for Alzheimer's Diagnosis Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Blood Tests for Alzheimer's Diagnosis by Company Revenue
3.2.2 Top 3 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2024
3.2.3 Top 6 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2024
3.3 Blood Tests for Alzheimer's Diagnosis Market: Overall Company Footprint Analysis
3.3.1 Blood Tests for Alzheimer's Diagnosis Market: Region Footprint
3.3.2 Blood Tests for Alzheimer's Diagnosis Market: Company Product Type Footprint
3.3.3 Blood Tests for Alzheimer's Diagnosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Blood Tests for Alzheimer's Diagnosis Consumption Value and Market Share by Type (2020-2025)
4.2 Global Blood Tests for Alzheimer's Diagnosis Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2020-2025)
5.2 Global Blood Tests for Alzheimer's Diagnosis Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2031)
6.2 North America Blood Tests for Alzheimer's Diagnosis Market Size by Application (2020-2031)
6.3 North America Blood Tests for Alzheimer's Diagnosis Market Size by Country
6.3.1 North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2031)
6.3.2 United States Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
6.3.3 Canada Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
6.3.4 Mexico Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2031)
7.2 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2031)
7.3 Europe Blood Tests for Alzheimer's Diagnosis Market Size by Country
7.3.1 Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2031)
7.3.2 Germany Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
7.3.3 France Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
7.3.5 Russia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
7.3.6 Italy Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Market Size by Region
8.3.1 Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2020-2031)
8.3.2 China Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
8.3.3 Japan Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
8.3.4 South Korea Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
8.3.5 India Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
8.3.7 Australia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2031)
9.2 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2031)
9.3 South America Blood Tests for Alzheimer's Diagnosis Market Size by Country
9.3.1 South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2031)
9.3.2 Brazil Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
9.3.3 Argentina Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Market Size by Country
10.3.1 Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2031)
10.3.2 Turkey Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
10.3.4 UAE Blood Tests for Alzheimer's Diagnosis Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Blood Tests for Alzheimer's Diagnosis Market Drivers
11.2 Blood Tests for Alzheimer's Diagnosis Market Restraints
11.3 Blood Tests for Alzheimer's Diagnosis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Blood Tests for Alzheimer's Diagnosis Industry Chain
12.2 Blood Tests for Alzheimer's Diagnosis Upstream Analysis
12.3 Blood Tests for Alzheimer's Diagnosis Midstream Analysis
12.4 Blood Tests for Alzheimer's Diagnosis Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 8. Roche Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Roche Recent Developments and Future Plans
Table 10. Quanterix Company Information, Head Office, and Major Competitors
Table 11. Quanterix Major Business
Table 12. Quanterix Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 13. Quanterix Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Quanterix Recent Developments and Future Plans
Table 15. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 16. Quest Diagnostics Major Business
Table 17. Quest Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 18. Quest Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. C?N Diagnostics Company Information, Head Office, and Major Competitors
Table 20. C?N Diagnostics Major Business
Table 21. C?N Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 22. C?N Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. C?N Diagnostics Recent Developments and Future Plans
Table 24. Fujirebio Company Information, Head Office, and Major Competitors
Table 25. Fujirebio Major Business
Table 26. Fujirebio Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 27. Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Fujirebio Recent Developments and Future Plans
Table 29. Diadem Company Information, Head Office, and Major Competitors
Table 30. Diadem Major Business
Table 31. Diadem Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 32. Diadem Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Diadem Recent Developments and Future Plans
Table 34. Labcorp Company Information, Head Office, and Major Competitors
Table 35. Labcorp Major Business
Table 36. Labcorp Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 37. Labcorp Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Labcorp Recent Developments and Future Plans
Table 39. Neurocode Company Information, Head Office, and Major Competitors
Table 40. Neurocode Major Business
Table 41. Neurocode Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 42. Neurocode Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Neurocode Recent Developments and Future Plans
Table 44. Cognitact Company Information, Head Office, and Major Competitors
Table 45. Cognitact Major Business
Table 46. Cognitact Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 47. Cognitact Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Cognitact Recent Developments and Future Plans
Table 49. Vazyme International Company Information, Head Office, and Major Competitors
Table 50. Vazyme International Major Business
Table 51. Vazyme International Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 52. Vazyme International Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Vazyme International Recent Developments and Future Plans
Table 54. KingMed Diagnostics Company Information, Head Office, and Major Competitors
Table 55. KingMed Diagnostics Major Business
Table 56. KingMed Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 57. KingMed Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. KingMed Diagnostics Recent Developments and Future Plans
Table 59. Hoyotek Company Information, Head Office, and Major Competitors
Table 60. Hoyotek Major Business
Table 61. Hoyotek Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 62. Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Hoyotek Recent Developments and Future Plans
Table 64. Global Blood Tests for Alzheimer's Diagnosis Revenue (USD Million) by Players (2020-2025)
Table 65. Global Blood Tests for Alzheimer's Diagnosis Revenue Share by Players (2020-2025)
Table 66. Breakdown of Blood Tests for Alzheimer's Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 67. Market Position of Players in Blood Tests for Alzheimer's Diagnosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 68. Head Office of Key Blood Tests for Alzheimer's Diagnosis Players
Table 69. Blood Tests for Alzheimer's Diagnosis Market: Company Product Type Footprint
Table 70. Blood Tests for Alzheimer's Diagnosis Market: Company Product Application Footprint
Table 71. Blood Tests for Alzheimer's Diagnosis New Market Entrants and Barriers to Market Entry
Table 72. Blood Tests for Alzheimer's Diagnosis Mergers, Acquisition, Agreements, and Collaborations
Table 73. Global Blood Tests for Alzheimer's Diagnosis Consumption Value (USD Million) by Type (2020-2025)
Table 74. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Share by Type (2020-2025)
Table 75. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Forecast by Type (2026-2031)
Table 76. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2025)
Table 77. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Forecast by Application (2026-2031)
Table 78. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 79. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 80. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 81. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 82. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 83. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 84. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 85. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 86. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 87. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 88. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 89. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 90. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 91. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 92. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 93. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 94. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2020-2025) & (USD Million)
Table 95. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2026-2031) & (USD Million)
Table 96. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 97. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 98. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 99. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 100. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 101. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 102. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 103. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 104. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 105. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 106. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 107. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 108. Global Key Players of Blood Tests for Alzheimer's Diagnosis Upstream (Raw Materials)
Table 109. Global Blood Tests for Alzheimer's Diagnosis Typical Customers
Table 1. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 8. Roche Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Roche Recent Developments and Future Plans
Table 10. Quanterix Company Information, Head Office, and Major Competitors
Table 11. Quanterix Major Business
Table 12. Quanterix Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 13. Quanterix Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Quanterix Recent Developments and Future Plans
Table 15. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 16. Quest Diagnostics Major Business
Table 17. Quest Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 18. Quest Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. C?N Diagnostics Company Information, Head Office, and Major Competitors
Table 20. C?N Diagnostics Major Business
Table 21. C?N Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 22. C?N Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. C?N Diagnostics Recent Developments and Future Plans
Table 24. Fujirebio Company Information, Head Office, and Major Competitors
Table 25. Fujirebio Major Business
Table 26. Fujirebio Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 27. Fujirebio Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Fujirebio Recent Developments and Future Plans
Table 29. Diadem Company Information, Head Office, and Major Competitors
Table 30. Diadem Major Business
Table 31. Diadem Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 32. Diadem Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Diadem Recent Developments and Future Plans
Table 34. Labcorp Company Information, Head Office, and Major Competitors
Table 35. Labcorp Major Business
Table 36. Labcorp Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 37. Labcorp Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Labcorp Recent Developments and Future Plans
Table 39. Neurocode Company Information, Head Office, and Major Competitors
Table 40. Neurocode Major Business
Table 41. Neurocode Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 42. Neurocode Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Neurocode Recent Developments and Future Plans
Table 44. Cognitact Company Information, Head Office, and Major Competitors
Table 45. Cognitact Major Business
Table 46. Cognitact Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 47. Cognitact Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Cognitact Recent Developments and Future Plans
Table 49. Vazyme International Company Information, Head Office, and Major Competitors
Table 50. Vazyme International Major Business
Table 51. Vazyme International Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 52. Vazyme International Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Vazyme International Recent Developments and Future Plans
Table 54. KingMed Diagnostics Company Information, Head Office, and Major Competitors
Table 55. KingMed Diagnostics Major Business
Table 56. KingMed Diagnostics Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 57. KingMed Diagnostics Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. KingMed Diagnostics Recent Developments and Future Plans
Table 59. Hoyotek Company Information, Head Office, and Major Competitors
Table 60. Hoyotek Major Business
Table 61. Hoyotek Blood Tests for Alzheimer's Diagnosis Product and Solutions
Table 62. Hoyotek Blood Tests for Alzheimer's Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Hoyotek Recent Developments and Future Plans
Table 64. Global Blood Tests for Alzheimer's Diagnosis Revenue (USD Million) by Players (2020-2025)
Table 65. Global Blood Tests for Alzheimer's Diagnosis Revenue Share by Players (2020-2025)
Table 66. Breakdown of Blood Tests for Alzheimer's Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 67. Market Position of Players in Blood Tests for Alzheimer's Diagnosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 68. Head Office of Key Blood Tests for Alzheimer's Diagnosis Players
Table 69. Blood Tests for Alzheimer's Diagnosis Market: Company Product Type Footprint
Table 70. Blood Tests for Alzheimer's Diagnosis Market: Company Product Application Footprint
Table 71. Blood Tests for Alzheimer's Diagnosis New Market Entrants and Barriers to Market Entry
Table 72. Blood Tests for Alzheimer's Diagnosis Mergers, Acquisition, Agreements, and Collaborations
Table 73. Global Blood Tests for Alzheimer's Diagnosis Consumption Value (USD Million) by Type (2020-2025)
Table 74. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Share by Type (2020-2025)
Table 75. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Forecast by Type (2026-2031)
Table 76. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2025)
Table 77. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Forecast by Application (2026-2031)
Table 78. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 79. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 80. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 81. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 82. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 83. North America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 84. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 85. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 86. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 87. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 88. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 89. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 90. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 91. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 92. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 93. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 94. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2020-2025) & (USD Million)
Table 95. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value by Region (2026-2031) & (USD Million)
Table 96. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 97. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 98. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 99. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 100. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 101. South America Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 102. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 103. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 104. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 105. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 106. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 107. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 108. Global Key Players of Blood Tests for Alzheimer's Diagnosis Upstream (Raw Materials)
Table 109. Global Blood Tests for Alzheimer's Diagnosis Typical Customers
LIST OF FIGURES
Figure 1. Blood Tests for Alzheimer's Diagnosis Picture
Figure 2. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type in 2024
Figure 4. Single Molecule Immunoassay Array Analysis
Figure 5. Chemiluminescence Method
Figure 6. Fluorescence PCR Method
Figure 7. Others
Figure 8. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application in 2024
Figure 10. Clinical Diagnosis Picture
Figure 11. Research Picture
Figure 12. Global Blood Tests for Alzheimer's Diagnosis Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Blood Tests for Alzheimer's Diagnosis Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market Blood Tests for Alzheimer's Diagnosis Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Region in 2024
Figure 17. North America Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Blood Tests for Alzheimer's Diagnosis Revenue Share by Players in 2024
Figure 24. Blood Tests for Alzheimer's Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of Blood Tests for Alzheimer's Diagnosis by Player Revenue in 2024
Figure 26. Top 3 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2024
Figure 27. Top 6 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2024
Figure 28. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Share by Type (2020-2025)
Figure 29. Global Blood Tests for Alzheimer's Diagnosis Market Share Forecast by Type (2026-2031)
Figure 30. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Share by Application (2020-2025)
Figure 31. Global Blood Tests for Alzheimer's Diagnosis Market Share Forecast by Application (2026-2031)
Figure 32. North America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 33. North America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 42. France Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Region (2020-2031)
Figure 49. China Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 52. India Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 56. South America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 66. Blood Tests for Alzheimer's Diagnosis Market Drivers
Figure 67. Blood Tests for Alzheimer's Diagnosis Market Restraints
Figure 68. Blood Tests for Alzheimer's Diagnosis Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Blood Tests for Alzheimer's Diagnosis Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Blood Tests for Alzheimer's Diagnosis Picture
Figure 2. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type in 2024
Figure 4. Single Molecule Immunoassay Array Analysis
Figure 5. Chemiluminescence Method
Figure 6. Fluorescence PCR Method
Figure 7. Others
Figure 8. Global Blood Tests for Alzheimer's Diagnosis Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application in 2024
Figure 10. Clinical Diagnosis Picture
Figure 11. Research Picture
Figure 12. Global Blood Tests for Alzheimer's Diagnosis Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Blood Tests for Alzheimer's Diagnosis Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market Blood Tests for Alzheimer's Diagnosis Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Region in 2024
Figure 17. North America Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Blood Tests for Alzheimer's Diagnosis Revenue Share by Players in 2024
Figure 24. Blood Tests for Alzheimer's Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of Blood Tests for Alzheimer's Diagnosis by Player Revenue in 2024
Figure 26. Top 3 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2024
Figure 27. Top 6 Blood Tests for Alzheimer's Diagnosis Players Market Share in 2024
Figure 28. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Share by Type (2020-2025)
Figure 29. Global Blood Tests for Alzheimer's Diagnosis Market Share Forecast by Type (2026-2031)
Figure 30. Global Blood Tests for Alzheimer's Diagnosis Consumption Value Share by Application (2020-2025)
Figure 31. Global Blood Tests for Alzheimer's Diagnosis Market Share Forecast by Application (2026-2031)
Figure 32. North America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 33. North America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 42. France Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Region (2020-2031)
Figure 49. China Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 52. India Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 56. South America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Blood Tests for Alzheimer's Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Blood Tests for Alzheimer's Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 66. Blood Tests for Alzheimer's Diagnosis Market Drivers
Figure 67. Blood Tests for Alzheimer's Diagnosis Market Restraints
Figure 68. Blood Tests for Alzheimer's Diagnosis Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Blood Tests for Alzheimer's Diagnosis Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
